These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16504804)

  • 1. The genetic heterogeneity of uterine leiomyomata.
    Lobel MK; Somasundaram P; Morton CC
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):13-39. PubMed ID: 16504804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
    Hodge JC; Morton CC
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetics of uterine leiomyomata].
    Pedeutour F; Ligon AH; Morton CC
    Bull Cancer; 1999 Nov; 86(11):920-8. PubMed ID: 10586108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression studies in leiomyomata: new directions for research.
    Catherino W; Salama A; Potlog-Nahari C; Leppert P; Tsibris J; Segars J
    Semin Reprod Med; 2004 May; 22(2):83-90. PubMed ID: 15164303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of uterine leiomyomata.
    Ligon AH; Morton CC
    Genes Chromosomes Cancer; 2000 Jul; 28(3):235-45. PubMed ID: 10862029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.
    Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC
    Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic aberrations and the development of uterine leiomyomata.
    El-Gharib MN; Elsobky ES
    J Obstet Gynaecol Res; 2010 Feb; 36(1):101-7. PubMed ID: 20178534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene.
    Ptacek T; Song C; Walker CL; Sell SM
    Cancer Genet Cytogenet; 2007 Apr; 174(2):116-20. PubMed ID: 17452252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in human uterine leiomyomas.
    Martel KM; Ko AC; Christman GM; Stribley JM
    Semin Reprod Med; 2004 May; 22(2):91-103. PubMed ID: 15164304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.
    Hayden MA; Ordulu Z; Gallagher CS; Quade BJ; Anchan RM; Middleton NR; Srouji SS; Stewart EA; Morton CC
    Cancer Genet; 2018 Apr; 222-223():1-8. PubMed ID: 29666002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal interval defined on 7q in uterine leiomyoma.
    Sell SM; Tullis C; Stracner D; Song CY; Gewin J
    Cancer Genet Cytogenet; 2005 Feb; 157(1):67-9. PubMed ID: 15676150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Uterine Fibroid Etiology.
    McWilliams MM; Chennathukuzhi VM
    Semin Reprod Med; 2017 Mar; 35(2):181-189. PubMed ID: 28278535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.
    Hodge JC; Quade BJ; Rubin MA; Stewart EA; Dal Cin P; Morton CC
    Am J Pathol; 2008 May; 172(5):1403-10. PubMed ID: 18403592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
    Crabtree JS; Jelinsky SA; Harris HA; Choe SE; Cotreau MM; Kimberland ML; Wilson E; Saraf KA; Liu W; McCampbell AS; Dave B; Broaddus RR; Brown EL; Kao W; Skotnicki JS; Abou-Gharbia M; Winneker RC; Walker CL
    Cancer Res; 2009 Aug; 69(15):6171-8. PubMed ID: 19622772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata.
    Xing YP; Powell WL; Morton CC
    Cancer Genet Cytogenet; 1997 Oct; 98(1):69-74. PubMed ID: 9309121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leiomyomata: heritability and cytogenetic studies.
    Ligon AH; Morton CC
    Hum Reprod Update; 2001; 7(1):8-14. PubMed ID: 11212080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in uterine fibroids - a new direction for pharmacological intervention?
    Markowski DN; Holzmann C; Bullerdiek J
    Expert Opin Ther Targets; 2015; 19(11):1485-94. PubMed ID: 26293838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
    Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
    Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Association Studies in Uterine Fibroids: Risk Alleles Presage the Path to Personalized Therapies.
    Gallagher CS; Morton CC
    Semin Reprod Med; 2016 Jul; 34(4):235-41. PubMed ID: 27513025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.